Skip to content
Baret News – Lifestyle
Author:
Krystal Biotech, Inc.
Krystal Biotech to Present at Upcoming Investor Conferences
November 10, 2026
Krystal Biotech Announces Third Quarter 2026 Financial and Operating Results
November 2, 2026
Krystal Biotech to Report Third Quarter 2026 Financial Results on November 2, 2026
October 22, 2026
Krystal Biotech Announces Positive Clinical Data for New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression in Patients with Gorlin Syndrome
October 15, 2026
Krystal Biotech to Present at 2026 Cantor Global Healthcare Conference
September 3, 2026
Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results
August 3, 2026
Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026
July 23, 2026
Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
May 21, 2026